Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek A Mann

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|July 31, 2007
Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axisAhmed M Elsharkawy, Derek A Mann
Journal of Hepatology|January 17, 2012
Clinical evidence for the regression of liver fibrosisElizabeth L Ellis, Derek A Mann
Clinical Science (London, England : 1979)|March 31, 2010
Role of nuclear factor kappaB in liver health and diseaseStuart M Robinson, Derek A Mann
Journal of Hepatology|December 22, 2009
NF-kappaB signalling: embracing complexity to achieve translationJayashree Bagchi Chakraborty, Derek A Mann
Nature Reviews. Gastroenterology & Hepatology|April 15, 2016
Liver: Osteopontin and HMGB1: novel regulators of HSC activationLee A Borthwick, Derek A Mann
Transplantation|July 11, 2025
Comment on "G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression"Abdullah K Malik, Derek A Mann
Current Pathobiology Reports|July 15, 2016
The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypesAgata Page, Derek A Mann, Jelena Mann
Plos One|November 14, 2015
Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer CellsLaura Corbett, Jelena Mann, Derek A Mann
Journal of Hepatology|June 11, 2013
Epigenetic modifications as new targets for liver disease therapiesMüjdat Zeybel, Derek A Mann, Jelena Mann
Journal of Gastrointestinal Cancer|February 11, 2025
Current Approaches of Pancreatic Cancer Surveillance in High-Risk IndividualsMelissa Heller, Derek A Mann, Bryson W Katona
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|July 31, 2007
Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axisAhmed M Elsharkawy, Derek A Mann
Journal of Hepatology|January 17, 2012
Clinical evidence for the regression of liver fibrosisElizabeth L Ellis, Derek A Mann
Clinical Science (London, England : 1979)|March 31, 2010
Role of nuclear factor kappaB in liver health and diseaseStuart M Robinson, Derek A Mann
Journal of Hepatology|December 22, 2009
NF-kappaB signalling: embracing complexity to achieve translationJayashree Bagchi Chakraborty, Derek A Mann
Nature Reviews. Gastroenterology & Hepatology|April 15, 2016
Liver: Osteopontin and HMGB1: novel regulators of HSC activationLee A Borthwick, Derek A Mann
Transplantation|July 11, 2025
Comment on "G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression"Abdullah K Malik, Derek A Mann
Current Pathobiology Reports|July 15, 2016
The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypesAgata Page, Derek A Mann, Jelena Mann
Plos One|November 14, 2015
Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer CellsLaura Corbett, Jelena Mann, Derek A Mann
Journal of Hepatology|June 11, 2013
Epigenetic modifications as new targets for liver disease therapiesMüjdat Zeybel, Derek A Mann, Jelena Mann
Journal of Gastrointestinal Cancer|February 11, 2025
Current Approaches of Pancreatic Cancer Surveillance in High-Risk IndividualsMelissa Heller, Derek A Mann, Bryson W Katona
Pageof 15